Chair Professor of Oncology. Breast cancer specialist. Translational cancer researcher. @oncaarhus. @AUHdk. @AarhusUni. @lunduniversity @obecare
Aarhus, Danmark
Joined October 2019
- Tweets156
- Following488
- Followers433
- Likes915
Signe Borgquist retweeted
At #ESMOBreast2025, Dr. @SixtenHarborg shared an analysis from the Nurses’ Health Study showing that weight gain after diagnosis may raise #breastcancer death risk. Study followed 6,800+ women between 1978 - 2018, with follow-up ranging from 4–15 years.
🔗bit.ly/ESMO2025
Signe Borgquist retweeted
Obesity➡️ worse prognosis & different biology #breastcancer.
Still, BMI is only reported in 8% of 495 trials we reviewed. More research needed to study impact of BMI on treatment efficacy and toxicity🙏 !
@Josephine_VC @VanBaelenKaren @OncoAlert
doi.org/10.1186/s13058-024-0…
Thank you for highlighting our research results - timely to consider metabolic screening among cancer patients! @jonasbh93 @jensbruu @ncfoDK @StenoAarhusRes @SDCOdense
📰 Patients with #breastcancer who have high levels of glycosylated hemoglobin have an increased risk of recurrence and death. #HbA1c #ESMOBreast24
👉 Read More: buff.ly/3wJBA7e
@myESMO #oncologynews @jensbruu
Signe Borgquist retweeted
📄 #Breastcancer survivors with #metabolicsyndrome have shorter disease-free survival than those without metabolic syndrome. #ESMOBreast24 #oncologynews @myESMO
🗞️ Read More: buff.ly/4dH8czf
Signe Borgquist retweeted
Important point by @ErikaHamilton9. A common questions from pts is: what should I take (or eat) to reduce my risk of recurrence? The answer to this question should not come from retrospective studies, often burdened by confounding bias, but should derive from RCTs. #ESMOBreast24
Signe Borgquist retweeted
So happy to be at the #ESMOBreast24 and share our results on the impact of metabolic syndrome on breast cancer outcomes🔬
BC patients with metabolic syndrome have poorer outcomes compared to their peers without metabolic syndrome ‼️
Read @mydocwire coverage of our study📰
📄 #Breastcancer survivors with #metabolicsyndrome have shorter disease-free survival than those without metabolic syndrome. #ESMOBreast24 #oncologynews @myESMO
🗞️ Read More: buff.ly/4dH8czf
Signe Borgquist retweeted
At #ESMOBreast24:
In a Danish population-based cohort 🇩🇰 study statin use ⬇️ breast cancer mortality 💊
Validation in prospective randomized trials is needed‼️
A phase 3 trial is ongoing classic.clinicaltrials.gov/c…
@OncoAlert
Signe Borgquist retweeted
Emulated target trial looking at #statins in early #bcsm
Those that received statins had ⬆️ survival.
🎯 Question is what other healthy behaviors are associated with statin use?
Hard to conclude much with study design, MASTER randomized will help.
#ESMOBreast24
@myESMO
Great morning at #ESMOBreast24 - awaiting our talented PhD-student @SixtenHarborg at @oncaarhus to talk - emulated target trial with statins in #breastcancer
Enjoying ESMO Breast 2024 with these amazing talents🇩🇪☀️💖
@jonasbh93 @SixtenHarborg @KaKjaergaard @Jeppe_Skovbjerg @KirstenWoolpert
#ESMOBreast24
Sikke en fantastisk dag! Samarbejde er ordet!
Glimt fra ph.d.-gruppens udflugt til Kræftens Bekæmpelses forskningsenhed. Det var en spændende og lærerig dag med formålet at fremme fremtidigt samarbejde på tværs af vores organisationer. Stort tak for invitationen. @cancer_dk #DanishCancerInstitute
Attending #SABCS2023 remotely from lovely @SkagenDenmark with this superb team of colleagues @BOffersen @TrineTramm @SixtenHarborg @jonasbh93 @Jeppe_Skovbjerg @kristinehogsbj1 @PSkovlund Martin & Lærke @oncaarhus @AarhusUni
Signe Borgquist retweeted
Obesity Linked to Increased Recurrence Rates in Breast Cancer curetoday.com/view/obesity-l…
Thanks @curetoday for the chat and for featuring our latest paper 📄 – at Arhus, Denmark
Magnificent contributions from @SixtenHarborg @jonasbh93 @PSkovlund in the field of obesity & cancer @DCCC_ObeCaRe @oncaarhus – at Syddjurs, Danmark
Powerful words in horrible times😢let”s hope the world is listening instagram.com/reel/CygWv0mI4…
Always a great privilege and joy to collaborate with such talented colleagues🙏🏻🙏🏻🙏🏻 - thank you all for all efforts to get this important publication out paving way for improving health in cancer patients ❤️ – at Arhus, Denmark
A huge thanks to my amazing supervisors @signeborgquist @DeeCroninFenton, Thomas P. Ahern and collaborators Marianne Ewerts and Maj-Britt Raaby Jensen for their great efforts in making this study happen 👩🔬👨🔬🌟
See our clinically important paper on obesity & inferior breast cancer prognosis - NEXT STEP: how do we circumvent this??
@SixtenHarborg @DeeCroninFenton @DCCC_ObeCaRe @oncaarhus @DCEAarhus @AUHdk @HealthAarhusUni @ncfoDK @cancer_dk – at Arhus, Denmark
UPDATE - OBESITY & BREAST CANCER RECURRENCE‼️
This study suggests that obesity is associated with an increased risk of recurrence among patients with hormone receptor–positive breast cancer treated with aromatase inhibitors‼️
jamanetwork.com/journals/jam…
Signe Borgquist retweeted
🤖Artificial intelligence as an adjunct tool for breast oncologists – are we there yet? Read this new editorial just published by @IlanaSchlam Saad Menezes, Adrian Y Tan, @CCortiMD @inas_md @stolaney1 to find out!
sciencedirect.com/science/ar…
Signe Borgquist retweeted
Super proud of #ESMOYOC team and grateful to @DrJonLim for leading on such an important position paper on role and future of the clinician-scientist in #oncology, a key topic for many YOs
@ESMO_Open @myESMO @OncoAlert @AIOMtweet @TeresaSAmaral @UniGenova
sciencedirect.com/science/ar…
